New Drug

J&J's Invokana clears FDA

By

The FDA has approved Janssen's Invokana (canagliflozin) for type 2 diabetes, giving J&J a first-to-market advantage in the SGLT-2 class.

Pent-up demand stands to drive Tecfidera, docs say

Pent-up demand stands to drive Tecfidera, docs say

By

Two-fifths of US neurologists polled said they're warehousing MS patients in anticipation of Tecfidera, though pricing worries could dampen sales.

Email Newsletters